LOS ANGELES (Legal Newsline) – A subsidiary of Johnson & Johnson will face a new trial over claims that its talcum powder caused ovarian cancer, a California appeals court has ruled. The appeals court also affirmed a ruling voiding a verdict awarding more than $400 million against the parent company.
NORMAN, Okla. (Legal Newsline) – Attorneys hired by the State of Oklahoma on July 1 filed a motion asking a judge to deny a request by lawyers for Johnson & Johnson to strike the testimony of a key state’s witness in a trial accusing J&J of creating an opioid epidemic.
NORMAN, Okla. (Legal Newsline) – A drug researcher on Tuesday told defense attorneys that opioid drugs sold by Janssen Pharmaceuticals are safe for pain relief, and later under questioning by state-hired attorneys declined to describe Oklahoma's situation as an epidemic.
NORMAN, Okla. (Legal Newsline) – Attorneys for Johnson & Johnson on Monday lost a bid to dismiss a lawsuit brought by contingency-fee lawyers hired by the State of Oklahoma who accused the company of creating an opioid epidemic.
NORMAN, Okla. (Legal Newsline) - Immediately after Oklahoma closed its case against Johnson & Johnson, the company last week filed a motion seeking judgment in its favor, telling the judge who is overseeing a trial that has lasted five weeks that the State failed to prove J&J caused the state’s opioid crisis.
NORMAN, Okla. (Legal Newsline) – An Oklahoma doctor appearing as a witness for Johnson & Johnson on Wednesday under questioning by state attorneys refused to use the word “epidemic” to describe the state’s opioid crisis, but conceded opioid overdose deaths had gone up in recent years.
NORMAN, Okla. (Legal Newsline) – A sales representative for Janssen Pharmaceuticals on Tuesday told a courtroom his company sold opioid drug products that were safe and effective, while attorneys for the State of Oklahoma contended the company harmed the public for profit.
NORMAN, Okla. (Legal Newsline) – A former researcher with Janssen Pharmaceuticals, the drug subsidiary of Johnson & Johnson, on Friday said the company’s opioid products were safe if used properly, while attorneys hired by Oklahoma alleged J&J had played loose with the facts.
CLEVELAND (Legal Newsline) - A proposed opioid “negotiation class” that would include more than 24,000 U.S. cities and counties is a waste of judicial resources unlikely to achieve its stated goal of hammering out a global settlement, say critics, including a former Connecticut official who was directly involved in negotiations with the opioid industry.